Related Experiment Video
Updated: May 12, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes
N E Corral-Fernández1, M Salgado-Bustamante, M E Martínez-Leija
1Laboratorio de Inmunología y Biología Celular y Molecular, Facultad de Ciencias Químicas, UASLP, San Luis Potosí, SLP, México.
Abstract:
MicroRNAs (miRNAs) are involved in gene regulation of several physiological processes. Alterations in the concentrations of miRNAs may result in cancer and autoimmune diseases. In cells of the immune system, miRNA expression is regulated by several cytokines and this expression is related to the inflammatory process. In the present work we evaluated miR-155 and miR-146a levels in peripheral blood mononuclear cells (PBMC) from patients with type 2 diabetes (T2D).We analysed the expression of miRNAs in PBMC from T2D patients (n=20) and control subjects (n=20) using real-time PCR. The quantity of IL-1β and IL-6 in culture supernatants was measured by ELISA.The basal expression of miR-155 and miR-146a in patients with T2D was decreased compared to control subjects and associated with age, gender and metabolic control but not with the therapeutic treatment used. We found significant correlations between the basal expression of miR-155 and miR-146a with HbA1c, Glucose and BMI, as well as of miR-155 expression stimulated by LPS with the values of TG, HbA1c, Glucose and BMI. Additionally, we detected an altered distribution of miR-155 and miR-146a expression related with HbA1c, glucose and BMI using the analysis of a three dimensional association of variables in the group of T2D patients.Downregulated levels of miR-155 could play an important role in the pathogenesis of T2D due to their relationship with metabolic control.
Insights
Decreased levels of miR-155 and miR-146a in peripheral blood mononuclear cells (PBMC) were observed in type 2 diabetes (T2D) patients. These microRNA (miRNA) changes correlate with metabolic control indicators like HbA1c and BMI.
Area of Science:
- Molecular Biology
- Immunology
- Endocrinology
Background:
- MicroRNAs (miRNAs) regulate gene expression and are implicated in diseases like cancer and autoimmune disorders.
- In immune cells, miRNA expression is modulated by cytokines and linked to inflammation.
- Altered miRNA levels are increasingly recognized in metabolic diseases.
Purpose of the Study:
- To investigate the expression levels of miR-155 and miR-146a in peripheral blood mononuclear cells (PBMC) of patients with type 2 diabetes (T2D).
- To explore the association between these miRNA levels and clinical parameters of T2D, including metabolic control.
Main Methods:
- Real-time PCR was used to analyze miR-155 and miR-146a expression in PBMC from T2D patients (n=20) and controls (n=20).
- Enzyme-linked immunosorbent assay (ELISA) measured IL-1β and IL-6 levels.
- Statistical analyses, including three-dimensional variable association, were employed.
Main Results:
- Basal expression of miR-155 and miR-146a was significantly decreased in T2D patients compared to controls.
- miRNA levels correlated with age, gender, HbA1c, glucose, and BMI, but not with therapeutic treatment.
- Stimulated miR-155 expression showed correlations with triglycerides (TG), HbA1c, glucose, and BMI.
Conclusions:
- Downregulated miR-155 and miR-146a expression in PBMC may be associated with type 2 diabetes.
- The observed alterations in miR-155 and miR-146a levels suggest a potential role in T2D pathogenesis, particularly concerning metabolic dysregulation.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
